CDKN2A and oligodendroglioma: In future studies, however, the existence of oligosarcomas as a distinct group of IDH-mutant tumors with frequent deletions of 1p/19q as well as CDKN2A/B should be considered in order to exclude an admixture with conventional oligodendrogliomas.